» Articles » PMID: 28025603

Evidence and Evidence Gaps of Laryngeal Cancer Surgery

Overview
Date 2016 Dec 28
PMID 28025603
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Surgical treatment of laryngeal cancer has been established for decades. In addition to total laryngectomy, which was first performed in 1873, a large number or organ preservation surgical techniques, like open partial laryngectomy, transoral laser microsurgery, and transoral robotic surgery have been developed. Studies on laryngeal cancer surgery are mainly retrospective case series and cohort studies. The evolution of chemoradiation protocols and their analysis in prospective randomized trials have led to an increasing acceptance of non-surgical treatment procedures. In addition to an improvement of prognosis, in recent years the preservation of function and maintenance of life quality after primary therapy of laryngeal cancer has increasingly become the focus of therapy planning. Significant late toxicity after chemoradiation has been identified as an important issue. This leads to a reassessment of surgical concepts and initiation of studies on laryngeal cancer surgery which was additionally stimulated by the advent of transoral robotic surgery in the US. Improving the evidence base of laryngeal cancer surgery by successful establishment of surgical trials should be the future goal.

Citing Articles

Reconstruction of laryngeal function by thyroid cartilage fenestration and draw-out resection followed by internal fixation with titanium microplates for early glottic carcinoma: a novel and efficient surgical approach.

Li Y, Ruan S, Hong Y, Zhuang F, Zheng C, Lu M Am J Transl Res. 2024; 16(6):2589-2598.

PMID: 39006276 PMC: 11236634. DOI: 10.62347/ATPE6857.


T1a Glottic Cancer: Advances in Vocal Outcome Assessment after Transoral CO-Laser Microsurgery Using the VEM.

Song W, Caffier F, Nawka T, Ermakova T, Martin A, Murbe D J Clin Med. 2021; 10(6).

PMID: 33802971 PMC: 8002749. DOI: 10.3390/jcm10061250.


Comparison of Current Surgical and Non-Surgical Treatment Strategies for Early and Locally Advanced Stage Glottic Laryngeal Cancer and Their Outcome.

Elicin O, Giger R Cancers (Basel). 2020; 12(3).

PMID: 32244899 PMC: 7140062. DOI: 10.3390/cancers12030732.


Mechanisms of IFNalpha-1a-Induced Apoptosis in a Laryngeal Cancer Cell Line.

Xin X, Zhang R, Yuan X, Liu L Med Sci Monit. 2019; 25:7100-7114.

PMID: 31542790 PMC: 6774267. DOI: 10.12659/MSM.917097.

References
1.
Morrissey A, OConnell D, Garg S, Seikaly H, Harris J . Radial forearm versus anterolateral thigh free flaps for laryngopharyngectomy defects: prospective, randomized trial. J Otolaryngol Head Neck Surg. 2010; 39(4):448-53. View

2.
Davis G, Schwartz S, Veenstra D, Yueh B . Cost comparison of surgery vs organ preservation for laryngeal cancer. Arch Otolaryngol Head Neck Surg. 2005; 131(1):21-6. DOI: 10.1001/archotol.131.1.21. View

3.
Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan C . Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg. 2004; 130(7):875-9. DOI: 10.1001/archotol.130.7.875. View

4.
Simo R, Bradley P, Chevalier D, Dikkers F, Eckel H, Matar N . European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer. Eur Arch Otorhinolaryngol. 2014; 271(9):2469-79. DOI: 10.1007/s00405-014-2966-x. View

5.
de Gier H, Knegt P, de Boer M, Meeuwis C, van der Velden L, Kerrebijn J . CO2-laser treatment of recurrent glottic carcinoma. Head Neck. 2001; 23(3):177-80. DOI: 10.1002/1097-0347(200103)23:3<177::aid-hed1015>3.0.co;2-8. View